NCT01841723 2026-03-18Ibrutinib in Treating Patients With Relapsed Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting44 enrolled
NCT03410875 2026-02-12A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell LeukemiaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting30 enrolled
NCT01199562 2026-01-28Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantCity of Hope Medical CenterActive not recruiting153 enrolled